Thioredoxin and thioredoxin-binding protein-2 in cancer and metabolic syndrome
- 6 June 2007
- journal article
- review article
- Published by Elsevier
- Vol. 43 (6) , 861-868
- https://doi.org/10.1016/j.freeradbiomed.2007.05.032
Abstract
No abstract availableKeywords
This publication has 94 references indexed in Scilit:
- Pancreatic B‐cell function is altered by oxidative stress induced by acute hyperglycaemiaDiabetic Medicine, 2007
- Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)Blood, 2006
- Recombinant human thioredoxin suppresses lipopolysaccharide-induced bronchoalveolar neutrophil infiltration in ratLife Sciences, 2006
- Exenatide inhibits β-cell apoptosis by decreasing thioredoxin-interacting proteinBiochemical and Biophysical Research Communications, 2006
- The Interaction of Thioredoxin with TxnipJournal of Biological Chemistry, 2006
- Gene expression profiling in INS-1 cells overexpressing thioredoxin-interacting proteinBiochemical and Biophysical Research Communications, 2005
- Two distinct mechanisms for loss of thioredoxin-binding protein-2 in oxidative stress-induced renal carcinogenesisLaboratory Investigation, 2005
- Cytoprotective Effects of Geranylgeranylacetone against Retinal Photooxidative DamageJournal of Neuroscience, 2005
- Heat shock factor regulates VDUP1 gene expressionBiochemical and Biophysical Research Communications, 2004
- Geranylgeranylacetone Enhances Expression of Thioredoxin and Suppresses Ethanol-Induced Cytotoxicity in Cultured HepatocytesBiochemical and Biophysical Research Communications, 2000